Active, not recruitingPhase 4NCT04227093

Acetazolamide Add-On Therapy to OSA Surgery

Studying Antisynthetase syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Antwerp
Principal Investigator
Olivier Vanderveken, MD, PhD
University Hospital, Antwerp
Intervention
Acetazolamide(drug)
Enrollment
26 enrolled
Eligibility
18-75 years · All sexes
Timeline
20202024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04227093 on ClinicalTrials.gov

Other trials for Antisynthetase syndrome

Additional recruiting or active studies for the same condition.

See all trials for Antisynthetase syndrome

← Back to all trials